The purpose of this study is to investigate the association of adverse environmental factors, parental psychopathology, family functioning and genetic factors and the response to methylphenidate treatment in children and adolescents with Attention Deficit/Hyperactivity Disorder.
Attention Deficit/Hyperactivity Disorder (ADHD) is a chronic disorder, with a worldwide estimated prevalence of 5,29%. It is associated with a high risk of functional impairment in many aspects of the patient´s life, such as academic achievements, peers relationships and physical injuries. There are few studies assessing predictive factors of clinical response to treatment. Different patterns of family functioning, such as high family conflict and low family cohesion might be associated with a poor treatment response, possibly mediating the effects of higher severity af the disorder and/or higher prevalence of comorbidity. Parental psychopathology has been associated with a poorer prognosis and is related with family functioning. Adverse social factors have long been studied and are associated with an increased risk for general mental disease, including ADHD, as well as a poorer prognosis. Different genetic factors have been studied and associated with different aspects of the disorder and different clinical responses to treatments. There are no studies evaluating how those factors interact with each other in a Brazilian population.
Study Type
INTERVENTIONAL
Allocation
NA
Masking
NONE
Enrollment
130
Dose increments according to clinical evaluation, starting with 0,3 mg/kg of weight/day
ADHD Outpatient Program - Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
SNAP -IV scores
Time frame: 1, 2, 3 and 6 months of treatment
CGI scores
Time frame: 1, 2, 3 and 6 months of treatment
Scores in CGAS
Time frame: 1, 2, 3 and 6 months of treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.